Related Experiment Videos
Different immune responses to UV-B-treated or -untreated donor spleen cells via portal vein administration
1Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Transplantation Proceedings
|December 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inferior Outcomes on the Waiting List in Low-Volume Pediatric Heart Transplant Centers.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Survival Outcomes Following Pediatric Liver Transplantation (Pedi-SOFT) Score: A Novel Predictive Index.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Biliary epithelial metastasis of squamous carcinoma of the anus.
Irish journal of medical science·2010
Mycophenolate mofetil: effects on clinical transplantation.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Evaluation of CYP3A Phenoconversion in Immunosuppressed Patients Following Kidney Transplantation.
Transplantation proceedings·2026
Short and Long-Term Results of Kidney Transplantation From Extended Criteria Donors.
Transplantation proceedings·2026
Hematopoietic Stem Cell Transplantation for the Management of Histiocytic Sarcoma: A Case Report and Systematic Review.
Transplantation proceedings·2026
Protection of Bevacizumab From Silicone Oil-Induced Inactivation by Liposomal Encapsulation.
Translational vision science & technology·2026
From immune heterogeneity to targeted therapies in IgG4-related disease.
Current opinion in rheumatology·2026